(NEW YORK) -- American pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a booster dose of their bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of their original vaccine. According to a... Read More.
(NEW YORK) -- Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday. The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with... Read More.
(NEW YORK) -- After decades of researching respiratory syncytial virus, an illness especially dangerous for newborns and the elderly, scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year. "Among very young children,... Read More.
(WASHINGTON) -- Pfizer's COVID-19 treatment Paxlovid has been hailed as a breakthrough in the fight against COVID-19. The pills have shown to dramatically reduce the risk of being hospitalized or dying for people who are at high-risk of COVID-19. But mounting evidence suggests Paxlovid may... Read More.
(NEW YORK) -- A panel of advisers at the Centers for Disease Control have greenlit the Pfizer and Moderna COVID-19 vaccines for kids as young as 6 months old, finding them both safe and effective. CDC Director Rochelle Walensky issued a recommendation for how doctors, nurses... Read More.
(WASHINGTON) -- The Food and Drug Administration has authorized the Pfizer and Moderna COVID-19 vaccines for kids as young as six months old, finding them both safe and effective. "Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this... Read More.
(WASHINGTON) -- Parents with young kids are one step closer to getting them vaccinated following a grueling wait for the last remaining group to be authorized for a vaccine. The process for authorization and recommendation from the regulatory agencies kicked off Wednesday with a meeting... Read More.
(NEW YORK) -- Pfizer announced Wednesday that it has completed its application to the U.S. Food and Drug Administration for a three-dose COVID-19 vaccine in children aged 6 months to under 5 years old, and the federal agency has accepted the application. "Pfizer and BioNTech... Read More.
(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old. The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
(NEW YORK) -- In the wake of the tragic milestone of 1 million official COVID-19 deaths in the United States, a new analysis found that without vaccines, the virus would have likely claimed more than 100,000 additional lives in 2021. The analysis, sponsored by Pfizer,... Read More.